Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00832208
Recruitment Status : Terminated
First Posted : January 30, 2009
Last Update Posted : January 21, 2016
Addis Ababa University
Information provided by (Responsible Party):
Drugs for Neglected Diseases